Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
YCBD 
cbdMD Inc (YCBD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: YCBD (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $3
1 Year Target Price $3
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -43.58% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 7.57M USD | Price to earnings Ratio 0.01 | 1Y Target Price 3 |
Price to earnings Ratio 0.01 | 1Y Target Price 3 | ||
Volume (30-day avg) 1 | Beta 2.17 | 52 Weeks Range 0.76 - 6.54 | Updated Date 08/15/2025 |
52 Weeks Range 0.76 - 6.54 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 86.16 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -0.81% | Operating Margin (TTM) -10.23% |
Management Effectiveness
Return on Assets (TTM) -6.23% | Return on Equity (TTM) -8.46% |
Valuation
Trailing PE 0.01 | Forward PE 714.29 | Enterprise Value 6952561 | Price to Sales(TTM) 0.39 |
Enterprise Value 6952561 | Price to Sales(TTM) 0.39 | ||
Enterprise Value to Revenue 0.35 | Enterprise Value to EBITDA 4.15 | Shares Outstanding 8908410 | Shares Floating 8753043 |
Shares Outstanding 8908410 | Shares Floating 8753043 | ||
Percent Insiders 16.1 | Percent Institutions 3.31 |
Upturn AI SWOT
cbdMD Inc
Company Overview
History and Background
cbdMD Inc., founded in 2014 as Level Brands, later rebranded as cbdMD in 2018. It quickly established itself as a significant player in the CBD industry by focusing on high-quality CBD products and widespread distribution. They became one of the first CBD companies to be publicly traded.
Core Business Areas
- CBD Products: Manufactures and distributes a wide range of CBD products, including tinctures, capsules, topicals, gummies, and pet products.
Leadership and Structure
The leadership team consists of Martin A. Sumichrast (Chairman & CEO) and David L. Gahm (CFO). The organizational structure is typical of a publicly traded company, with departments focusing on product development, marketing, sales, and operations.
Top Products and Market Share
Key Offerings
- CBD Tinctures: One of their core offerings, with various strengths and flavors. Market share information is difficult to ascertain due to the fragmented nature of the CBD market. Competitors include Charlotte's Web (CWBHF), CV Sciences (CVSI), and various private label brands.
- CBD Gummies: CBD-infused gummies offer a convenient and palatable way to consume CBD. Competitors include Charlotte's Web (CWBHF), CV Sciences (CVSI), and various private label brands.
- CBD Topicals: CBD creams, lotions, and balms designed for targeted relief. Competitors include Charlotte's Web (CWBHF), CV Sciences (CVSI), and various private label brands.
- CBD Pet Products: A line of CBD products formulated specifically for pets. Competitors include Charlotte's Web (CWBHF) and various private label brands specializing in pet CBD products.
Market Dynamics
Industry Overview
The CBD industry is highly competitive and fragmented, experiencing rapid growth but also facing regulatory uncertainty and evolving consumer preferences. The industry is transitioning into one with increased regulation and potentially tighter rules with respect to marketing and product development.
Positioning
cbdMD Inc. aims to position itself as a trusted provider of high-quality, broad-spectrum CBD products. They rely heavily on brand recognition and athlete sponsorships.
Total Addressable Market (TAM)
Estimates for the CBD market vary, but projections often place it in the multi-billion dollar range. cbdMD Inc. is positioned to capture a portion of this market through its diversified product line and established brand.
Upturn SWOT Analysis
Strengths
- Brand Recognition
- Broad Product Line
- Established Distribution Network
- Publicly Traded Status
Weaknesses
- Lack of Profitability
- Reliance on Single Industry
- High Marketing Expenses
- Significant Competition
Opportunities
- Expanding Product Lines
- International Expansion
- Strategic Partnerships
- Lobbying for Favorable Regulations
Threats
- Regulatory Uncertainty
- Increased Competition
- Fluctuations in Raw Material Prices
- Changing Consumer Preferences
Competitors and Market Share
Key Competitors
- CWBHF
- CVSI
- SMG
Competitive Landscape
cbdMD Inc. faces stiff competition in a fragmented market. They need to differentiate themselves through product quality, branding, and strategic partnerships.
Growth Trajectory and Initiatives
Historical Growth: Past growth has been tied to the overall expansion of the CBD market. However, recent financial results suggest a slowing growth rate.
Future Projections: Future growth depends on the company's ability to innovate, expand into new markets, and navigate the evolving regulatory landscape.
Recent Initiatives: Recent initiatives have focused on product innovation and marketing campaigns.
Summary
cbdMD Inc. is a well-known brand in the competitive CBD market. While they possess strengths in brand recognition and product variety, profitability remains a challenge. Navigating regulatory hurdles and staying ahead of evolving consumer tastes will be crucial for sustained success. They have not made any significant acquisitions.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market share data is approximate and based on available industry reports. Financial data needs to be populated from company reports for accuracy.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About cbdMD Inc
Exchange NYSE MKT | Headquaters Charlotte, NC, United States | ||
IPO Launch date 2019-04-29 | Interim CEO, CFO, Principal Executive Officer & Director Mr. T. Ronan Kennedy | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 42 | Website https://www.cbdmd.com |
Full time employees 42 | Website https://www.cbdmd.com | ||
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.